Insys Therapeutics (INSY)

4.39 +0.25 (6.04%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (5/8/19 *Est.)

Latest Headlines

Insys Therapeutics (INSY) call put ratio 1 call to 1.3 puts as shares sell off 22% March 13, 2019 12:36 PM - StreetInsider Insys Therapeutics (INSY) Halted on LUDP March 13, 2019 9:54 AM - StreetInsider Insys Therapeutics (INSY) Declines After Filing 10-K, Includes Going Concern Statement March 13, 2019 9:53 AM - StreetInsider Form 10-K Insys Therapeutics, Inc. For: Dec 31 March 13, 2019 6:07 AM - SEC Filing INSYS Therapeutics (INSY) PT Lowered to $7 at RBC Capital March 8, 2019 6:29 AM - StreetInsider Insys Therapeutics (INSY) Misses Q4 EPS by 8c March 7, 2019 4:26 PM - StreetInsider INSYS Therapeutics Reports Fourth Quarter and Full Year 2018 Results March 7, 2019 4:15 PM - Globe NewsWire Form 8-K Insys Therapeutics, Inc. For: Mar 07 March 7, 2019 4:14 PM - SEC Filing Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC March 7, 2019 11:24 AM - SEC Filing INSYS Therapeutics to Report Fourth Quarter and Full Year 2018 Results on March 7 March 6, 2019 4:15 PM - Globe NewsWire Form SC 13G/A Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC February 26, 2019 1:23 PM - SEC Filing Insys Therapeutics (INSY) Highlights Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment of Allergic Reactions (Type I) February 25, 2019 6:13 AM - StreetInsider INSYS Therapeutics Presented Poster of Initial Pharmacokinetic Study of Epinephrine Nasal Spray for the Emergency Treatment of Allergic Reactions (Type I) including Anaphylaxis at American Academy of February 25, 2019 6:00 AM - Globe NewsWire Form SC 13G Insys Therapeutics, Inc. Filed by: ETF MANAGERS GROUP, LLC February 19, 2019 2:06 PM - SEC Filing Form SC 13G/A Insys Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC February 13, 2019 6:15 AM - SEC Filing Cantor Fitzgerald Starts INSYS Therapeutics (INSY) at Overweight January 22, 2019 6:16 AM - StreetInsider Insys Therapeutics (INSY) Reports Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis January 9, 2019 6:08 AM - StreetInsider Former Insys CEO pleads guilty to opioid kickback scheme January 9, 2019 6:04 AM - StreetInsider INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis January 9, 2019 6:00 AM - Globe NewsWire INSYS Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference January 3, 2019 6:00 AM - Globe NewsWire Ex-Insys CEO to plead guilty to opioid kickback scheme December 26, 2018 4:56 PM - StreetInsider Janney Montgomery Scott Assumes INSYS Therapeutics (INSY) at Buy December 19, 2018 7:08 AM - StreetInsider New Hampshire physician assistant guilty of Insys opioid kickback scheme December 18, 2018 2:46 PM - StreetInsider Insys Therapeutics (INSY) Provides Upadate on FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone December 18, 2018 6:12 AM - StreetInsider INSYS Therapeutics Announces Participation at FDA Advisory Committee Meeting Addressing the Co-Prescribing of Naloxone December 18, 2018 6:00 AM - Globe NewsWire Full Article List